SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 30, 2002 (December 30, 2002)
ENDO PHARMACEUTICALS HOLDINGS INC.
| DELAWARE | 39040 | 13-4022871 | ||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
||||
| 100 Painters Drive Chadds Ford, Pennsylvania |
19317 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(610) 558-9800
N/A
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 9. Regulation FD Disclosure. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| PRESS RELEASE | ||||||||
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
| Exhibit Number | Description | |
| 99.1 | Press Release of Endo Pharmaceuticals Holdings Inc. dated December 30, 2002 |
Item 9. Regulation FD Disclosure.
On December 30, 2002, the Registrant issued a press release, a copy of which is attached as Exhibit 99.1 to this Report and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. (Registrant) |
||||
| By: | /s/ Carol A. Ammon | |||
|
Name: Title: |
Carol A. Ammon Chairman & Chief Executive Officer |
|||
Dated: December 30, 2002
INDEX TO EXHIBITS
| Exhibit Number | Description | |
| 99.1 | Press Release of Endo Pharmaceuticals Holdings Inc. dated December 30, 2002 |